Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Salix Acquires Santarus: Synergies And Analyst Sentiment

This article was originally published in The Pink Sheet Daily

Executive Summary

Some analysts balked, but Salix management defended the price the company is paying for Santarus on a Nov. 7 earnings call, arguing that synergies from an integration support the valuation of six to seven times the sales price.

Advertisement

Related Content

ViroPharma Talks Cinryze Sales, EU Launches
Persistence, Secondary Endpoints Helped Shire Get FDA Nod For Firazyr Novel PRO

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS075135

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel